Clinical Trial Detail

NCT ID NCT00620633
Title Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

bone marrow cancer

leukemia

Therapies

ATA520

Age Groups: adult

No variant requirements are available.